A fantastic video that clearly explains the role of mRNA and the cellular mechanisms involved. Watch it: it explains these mechanisms in a way that is now indisputable.
Published on 5 February 2026 by pgibertie and
“This mRNA technology combined with lipid nanoparticles reaches every organ system in our body. Cells absorb it easily because they appreciate the composition of the outer membrane – a near-perfect cell-opening mechanism. Inside, the modified mRNA is released, migrates to the ribosomes and instructs the cells to produce a toxic, highly pathogenic, non-human protein: the Spike protein”.
Suddenly, neurons, cardiac muscle cells (cardiomyocytes) and many other cell types begin to express this foreign, toxic protein on their surface. These are not conventional vaccines.
These are gene therapy technologies – and dangerous ones at that.
At the same time, the Association of Research-Based Pharmaceutical Companies (VFA) openly predicts that mRNA vaccines will be used in many future vaccinations. (see: http: //lnkd.in/dapJD6uQ ) A common misconception, unfortunately still propagated by many experts: “mRNA is a natural component of every cell in the body.” Endogenous messenger RNA is essential. However, the modified RNA (mRNA) used in vaccines is quite different: artificially produced, made more stable and foreign to the body, it penetrates all types of cells, including nerve cells and stem cells, and can even reach the nucleus. The proteins it produces can be defective, potentially promoting disease rather than preventing it. These differences are almost never discussed in public.
Any doctor who administers these “vaccinations” should be fully aware of this and have this fundamental knowledge of cell biology. Share this post and spread this knowledge!
mRNA vaccines, such as those from Pfizer-BioNTech or Moderna, effectively use lipid nanoparticles (LNPs) to encapsulate the modified mRNA. These LNPs facilitate entry into cells by mimicking natural lipid structures, enabling the mRNA to reach ribosomes to produce the SARS-CoV-2 Spike protein.
pmc.ncbi.nlm.nih.gov This protein is designed to mimic that of the virus, stimulating an immune response without causing disease. However, studies have shown that these vaccines can distribute mRNA to various organs (liver, spleen, muscles, and sometimes the brain or heart).
bpspubs.onlinelibrary.wiley.com Hypothetical research suggests that this could lead to expression of the Spike protein in non-target cells, such as cardiomyocytes or neurons, potentially toxic if it triggers chronic inflammation or autoimmunity. pmc.ncbi.nlm.nih.gov +1 Concerns exist about its potential toxicity: some studies indicate that it could cause vascular or inflammatory damage if expressed over a prolonged period.
thelancet.com Risks include rare integration into DNA via endogenous reverse transcriptase, although this is considered unlikely and unproven in humans.
pmc.ncbi.nlm.nih.gov Post-vaccination studies have detected mRNA persisting in tissues for up to 30 days, with Spike proteins potentially frameshifted, which could produce defective variants.
Vaccine mRNA (often called modified or pseudouridylated mRNA) differs from the body’s natural mRNA:
- Stability: Endogenous mRNA is degraded rapidly (hours), while vaccine mRNA is modified (for example, with N1-methylpseudouridine) to resist enzymes and prolong protein production. sciencedirect.com +1
- Cell penetration: LNPs make it easier to penetrate various cell types, including stem and nerve cells, unlike endogenous mRNA, which is produced and used locally. encyclopedia.pub
- Risks: This could suppress innate immune responses or cause defective proteins that promote autoimmune or inflammatory diseases.
The VFA (Verband Forschender Arzneimittelhersteller, the German association of research-based pharmaceutical companies) does indeed foresee a wider use of mRNA vaccines for other diseases. According to their publications, around 125 mRNA-based drugs are in development for vaccines against cancer, influenza, HIV and other infections. schott.com +1 They highlight the advantages: rapid production, scalability and easy adaptation (for example, adding proteins such as nucleocapsid for broader protection).
